QT
Quanta Therapeutics, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$76.2Msold at filing
Total offering$89.1M$12.9M still open
Investors in the raise17count reported to the SEC
FiledJun 24, 2026first sale May 10, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Maha KatabiDirector
Perry NisenExecutive Officer, Director
Cameron PittExecutive Officer, Director
Maria FardisDirector
Ying HuangDirector
Derek MetzgerExecutive Officer
Rajul JainDirector
Executive officers, directors and promoters as listed on the Form D.